2023-11-14T03:42:05-00:00 2022-12-31 834701972 LEWIS SHARPSTONE & CO 5850 CANOGA AVE SUITE 400 WOODLAND HILLS CA 91367 990 2022-01-01 954640311 HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH HIRS 3104735121 2990 S SEPULVEDA BLVD STE 300C Los Angeles CA 90064 AGNES BERLINER HIRSHBERG FOUNDER AND PRESIDENT 3104735121 2023-11-14 true AGNES BERLINER HIRSHBERG 999009999 LEWIS SHARPSTONE P02256953 8185701960 2023-11-14 X 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z AGNES BERLINER HIRSHBERG 2990 S SEPULVEDA BLVD Los Angeles CA 90064 5522813 false X www.pancreatic.org X 1997 CA TO FUND RESEARCH AND GRANTS, SUPPORT PATIENTS AND THEIR FAMILIES, PROVIDE INFORMATION AND PROMOTE AWARENESS OF ADVANCED TREATMENT OPTIONS FOR PANCREATIC CANCER. 7 6 7 500 0 1903602 2426703 0 305878 -10602 0 2209480 2416101 745020 1500996 0 548004 667176 0 300231 237491 479401 1530515 2647573 678965 -231472 3850011 3413242 368137 3850011 3045105 FOUNDED IN 1997, THE HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH IS A NATIONAL, NONPROFIT ORGANIZATION DEDICATED TO ADVANCING PANCREATIC CANCER RESEARCH, AND PROVIDING INFORMATION, RESOURCES, AND SUPPORT TO PANCREATIC CANCER PATIENTS AND THEIR FAMILIES. false false 1670592 1486316 THE RESEARCH PROGRAMS INCLUDE VARIOUS GRANTS AND COMMITMENTS TO FURTHER RESEARCH INTO FINDING A CURE FOR PANCREATIC CANCER. THROUGH OUR SEED GRANT PROGRAM WE SUPPORT BASIC AND CLINICAL SCIENTISTS AND INVESTIGATORS IN THE US AND ABORAD, AWARDING MORE THAN 112 GRANTS SINCE 2005 AND FUNDING 48 MEDICAL RESEARCH INSTITUTIONS GLOBALLY. THE UCLA AGI HIRSHBERG CENTER FOR PANCREATIC DISEASES PROVIDES A CRITICAL HUB FOR ADVANCING RESEARCH AND TREATMENT BREAKTHROUGHS. WE FUND 3 LABORATORIES AT UCLA FOCUSING ON BASIC AND TRANSLATIONAL SCIENCE. WE FUND A PANCREAS TISSUE BANK. 270378 14680 THE PATIENT SUPPORT PROGRAMS PROVIDE INFORMATION AND GUIDANCE TO PATIENTS AND CAREGIVERS, INCLUDING COUNSELING AND SUPPORT GROUPS, ALTERNATIVE MEDICINE, CLINICAL TRIAL UPDATES, PATIENT ADVOCACY, FINANCIAL AID AND GENETIC COUNSELING. OUR ANNUAL SYMPOSIUM IS PATIENT CENTERED EDUCATION PROGRAM THAT HAS INTEGRATED NEARLY 200 RESEARCHERS, CLINICIANS, PATIENTS AND FAMILIES TO LEARN ABOUT DEVELOPMENTS, TREATMENTS AND PROGRESSION OF FINDING A CURE. OUR PATIENT AND FAMILY WEBINAR SERIES IS AN INTERACTIVE SERIES CONNECTING SPECIALISTS WITH THE PANCREATIC CANCER COMMUNITY. 1940970 true true false false false false false false false false true false false false true true true false false false false false false false true false false true true true false false false false false false false false true false false false false false false false false true 13 0 7 true false false false false false true true false false false false false false false X 7 6 true false false false false false false true true false false true true true true true false false true false false CA X LEONARD ALTADONNA 8184497920 6300 CANOGA AVE SUITE 1330 WOODLAND HILLS CA 91367 LISA MANHEIM CHIEF EXECUTIVE OFFICER, DIRECTOR 040.00 X X 225000 0 0 AGNES BERLINER HIRSHBERG DIRECTOR, PRESIDENT 040.00 X X 0 0 4408 MICHAEL SCOTT ESQ DIRECTOR 001.00 X 0 0 0 JON HIRSHBERG DIRECTOR 001.00 X 0 0 0 LISA HIRSHBERG DIRECTOR 001.00 X 0 0 0 MICHAEL BERLINER DIRECTOR 001.00 X 0 0 0 LEONARD ALTADONNA CPA DIRECTOR 001.00 X 0 0 0 225000 4408 1 false true false 1589142 837561 30839 2426703 125067 125067 2413010 2548679 -135669 -135669 -135669 558033 1589142 558033 2416101 -10602 1486316 1486316 14680 14680 0 0 212741 127645 10637 74459 0 379917 174762 79783 125372 0 34135 17011 5561 11563 40383 18576 8480 13327 0 0 42150 42150 0 28794 28794 53681 53681 14566 14566 58188 1920 37965 18303 131023 5652 121602 3769 0 79259 40422 11889 26948 7730 7730 0 0 0 0 9144 4664 1372 3108 14852 7575 2228 5049 SYMPOSIUM COSTS 32325 32325 TELEPHONE, TELECOMMUNICATIONS 7689 1692 2230 3767 0 2647573 1940970 406372 300231 X 145404 248315 591345 119058 47772 7163 164495 116338 57178 48157 3008312 2694074 296475 3850011 3413242 368137 0 368137 X 3850011 3045105 3850011 3045105 3850011 3413242 X -231472 -724109 150675 X X false true X true false X 1783252 1914980 1591064 1903602 2426703 9619601 1783252 1914980 1591064 1903602 2426703 9619601 861896 8757705 39504 46115 95266 125067 305952 9925553 0.88230 0.85630 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 130385 82138 48157 34110 34100 48157 Financial derivatives and other financial products Closely-held equity interests Federal income taxes RIGHT OF USE LIABILITY 368137 368137 X 1663198 -724109 -724109 2387307 28794 28794 2416101 2618779 2618779 28794 28794 2647573 X 2 THE ORGANIZATION HAS EVALUATED ITS TAX POSITIONS AND THE CERTAINTY AS TO WHETHER THOSE POSITIONS WILL BE SUSTAINED IN THE EVENT OF AN AUDIT BY THE TAXING AUTHORITIES AT THE FEDERAL OR STATE LEVELS. MANAGEMENT HAS DETERMINED THAT ALL TAX POSITIONS WILL MORE LIKELY THAN NOT BE SUSTAINED UPON POTENTIAL AUDIT. CA TOUR DE PEIR 1464094 1163053 301041 301041 LACC 562103 329275 232828 232828 1 120978 96814 24164 24164 2147175 1589142 558033 558033 558033 true UNCLE KORY FOUNDATION 2121 ROSENCRANS AVE EL SEGUNDO CA 90245 464485313 501C3 711572 FUND RESEARCH THE UCLA FOUNDATION 10889 WILSHIRE BLVD 1100 LOS ANGELES CA 90024 952250801 501C3 270000 FUND RESEARCH CANCER SUPPORT CUMMUNITY (DELETED) 2601 AIRPORT DRIVE SUITE 100 TORRANCE CA 90505 954163931 501C3 170000 FUND RESEARCH UC REGENTS 1111 FRANKLIN ST 12 FL OAKLAND CA 94607 946036493 501C3 89000 FUND RESEARCH AMERICAN PANCREATIC ASSOCIATION PO BOX 14906 MINNEAPOLIS MN 55414 431422062 501C3 40000 FUND RESEARCH BAYLOR COLLEGE OF MEDICINE PO BOX 301270 DALLAS TX 753031207 741613878 501C3 40000 FUND RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 555 WESTWOOD PLAZA SUITE 100 LOS ANGELES CA 90095 943067788 501C3 40000 FUND RESEARCH HEALTH RESEARCH INC - ROSWELL PARK DIVI 150 BROADWAY STE 280 MENANDS NY 12204 141402155 501C3 40000 FUND RESEARCH THE UNIVERSITY OF CHICAGO - ATTN MARY SZA 6054 S DREXEL AVE SUITE 300 CHICAGO IL 60637 362177139 501C3 40000 FUND RESEARCH CANCER CARE 275 SEVENTH AVE NEW YORK NY 10001 131825919 501C3 30000 FUND RESEARCH NCCN FOUNDATION 3025 CHEMINCAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 271536314 501C3 10000 FUND RESEARCH COLLABORATIVE ALLIANCES FOR PANCREATIC EDUCATION AND RESEARCH PO BOX 219191 KANSAS CITY MO 641219191 263056180 501C3 5000 FUND RESEARCH 11 1 GRANTS TO INDIVIDUALS 9 14680 Part I Line 2 PROCEDURES FOR MONITORING USE OF GRANT FUNDS IN U.S. THE CHARITYS SCIENTIFIC ADVISORY BOARD REGULARLY REVIEWS GRANT USAGE. X X X false false false false false false false false false LISA MANHEIM CHIEF EXECUTIVE OFFICER, DIRECTOR 225000 225000 Part II Line 1 DURING THE YEAR, THE CEO DID NOT RECEIVE A BONUS HOWEVER, IN SEPTEMBER 2022 THE INDIVIDUAL RECEIVED A 25 INCREASE IN THEIR SALARY. X 1 6339 QUOTED MARKET VALUE X AUCTION ITEMS 3 24500 ESTIMATED FAIR VALUE false false Part I Line 9 AND 25 THE NUMBERS IN COLUMN B REPRESENTS THE NUMBER OF INDIVIDUAL DONORS. Form 990, Part VI, Section A, Line 2 THE FOUNDATIONS CEO AND PRESIDENT ARE DAUGHTER AND MOTHER. JON HIRSHBERG AND LISA MANHEIM ARE FAMILY MEMBERS OF THE CEO AND PRESIDENT. LISA MANHEIM AND MIKE BERLINER ARE SIBLINGS. Form 990, Part VI, Section B, Line 11B THE FOUNDATIONS CEO AND THE CPA ON THE BOARD REVIEWS AND APPROVES THE FORM 990, AND IT IS PROVIDED TO THE BOARD PRIOR TO FILING. Form 990, Part VI, Section B, Line 12C THE BOARD OF DIRECTORS ON AN ANNUAL BASIS AND INFORMALLY, AFFIRM THEIR KNOWLEDGE OF THE CONFLICT OF INTEREST POLICY. TO THE EXTENT THAT A CONFLICT RELATIONSHIP IS IDENTIFIED, THE BOARD DISCUSSES ANY RESOLUTION PER THE POLICY. Form 990, Part VI, Section B, Line 15A THE OFFICERS CONSIDER ANY MODIFICATIONS TO THE CEOS SALARY. THE COMMITTEE REVIEWS RELATED SALARIES IN THE MARKET PLACE USING FORM 990 DISCLOSURES OF OTHER SIMILAR CHARITIES. Form 990, Part VI, Section C, Line 19 THE FOUNDATION MAKES ITS GOVERNANCE DOCUMENTS AND POLICIES AVAILABLE FOR INSPECTION UPON WRITTEN REQUEST. Form 990, Part VI, Section B, Line 15B THIS IS ANSWERED NO SINCE THERE ARE NO SUCH INDIVIDUALS TO WHICH THIS APPLIES. Form 990, Part XII, Line 2B AND C THE FOUNDATION IS AWARE THAT IT IS REQUIRED TO OBTAIN 2022 AUDITED FINANCIAL STATEMENTS. THE FOUNDATION HAS CONTRACTED FOR SUCH AND IT WILL BE COMPLETED AS SOON AS POSSIBLE UPON COMPLETION OF THE 2021 AUDIT. Form 990, Part X, Line 31 THE FOUNDATION DOES NOT CURRENTLY FOLLOW ASC 958 IN ITS FORM 990. AFTER THE FOUNDATION COMPLETES ITS FIRST AUDIT, IT WILL FOLLOW ASC 958 AND LINES 27 AND 28 WILL BE UTILIZED ON A GO FORWARD BASIS. ANY ENDOWMENT FUNDS REPORTED IN THE AUDIT WILL ALSO BE REPORTED ON SCHEDULE D PART V. Form 990, Part XII, Line 1 DURING 2022 THE ORGANIZATION CHANGED ITS METHOD OF ACCOUNTING FROM CASH TO ACCRUAL, IN ORDER TO ALIGN ITS METHOD OF ACCOUNTING ON THE 990 WITH THAT WHICH WILL BE USED FOR ITS ANNUAL AUDITED FINANCIAL STATEMENTS. Form 990, Part XI, Line 9 IN ADJUSTING ITS BASIS OF ACCOUNTING FROM CASH TO ACCRUAL, AND ALSO IN ATTEMPTING TO PREPARE ITS ACCOUNTING RECORDS TO UNDERGO AUDITS FOR THE YEAR ENDED DECEMBER 31, 2021, THE ORGANIZATION MADE ADJUSTMENTS TO ITS RETAINED EARNINGS AS PREVIOUSLY REPORTED ON ITS 2021 FORM 990. THE NET EFFECT OF THESE ADJUSTMENTS WAS 150,675. Form 990, Part X, Line 17 THIS RETURN HAS BEEN PREPARED BASED ON INFORMATION PROVIDED BY THE ORGANIZATION. THE ORGANIZATION HAS STRUGGLED WITH ITS CASH TO ACCRUAL CONVERSION. ACCORDINGLY, SOME NUMBERS IN THIS RETURN MAY NOT BE ACCURATE. ONE EXAMPLE IS THE NEGATIVE ACCOUNTS PAYABLE BALANCE AS REPORTED ON THIS LINE ITEM.